These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 26699403)

  • 1. Regulation of Histone Acetylation by Autophagy in Parkinson Disease.
    Park G; Tan J; Garcia G; Kang Y; Salvesen G; Zhang Z
    J Biol Chem; 2016 Feb; 291(7):3531-40. PubMed ID: 26699403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition.
    Harrison IF; Smith AD; Dexter DT
    Neurosci Lett; 2018 Feb; 666():48-57. PubMed ID: 29273397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone hyperacetylation up-regulates protein kinase Cδ in dopaminergic neurons to induce cell death: relevance to epigenetic mechanisms of neurodegeneration in Parkinson disease.
    Jin H; Kanthasamy A; Harischandra DS; Kondru N; Ghosh A; Panicker N; Anantharam V; Rana A; Kanthasamy AG
    J Biol Chem; 2014 Dec; 289(50):34743-67. PubMed ID: 25342743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manganese chloride induces histone acetylation changes in neuronal cells: Its role in manganese-induced damage.
    Guo Z; Zhang Z; Wang Q; Zhang J; Wang L; Zhang Q; Li H; Wu S
    Neurotoxicology; 2018 Mar; 65():255-263. PubMed ID: 29155171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?
    Harrison IF; Dexter DT
    Pharmacol Ther; 2013 Oct; 140(1):34-52. PubMed ID: 23711791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired Mitophagy and Protein Acetylation Levels in Fibroblasts from Parkinson's Disease Patients.
    Yakhine-Diop SMS; Niso-Santano M; Rodríguez-Arribas M; Gómez-Sánchez R; Martínez-Chacón G; Uribe-Carretero E; Navarro-García JA; Ruiz-Hurtado G; Aiastui A; Cooper JM; López de Munaín A; Bravo-San Pedro JM; González-Polo RA; Fuentes JM
    Mol Neurobiol; 2019 Apr; 56(4):2466-2481. PubMed ID: 30032424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imbalance of Lysine Acetylation Contributes to the Pathogenesis of Parkinson's Disease.
    Wang R; Sun H; Wang G; Ren H
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
    Hutt DM; Roth DM; Marchal C; Bouchecareilh M
    Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting histone acetylation for neuroprotection.
    Contestabile A
    Curr Pharm Des; 2013; 19(28):5017-8. PubMed ID: 23448467
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of histone acetylation and deacetylation enzymes affects longevity, development, and fecundity in the pea aphid (Acyrthosiphon pisum).
    Kirfel P; Skaljac M; Grotmann J; Kessel T; Seip M; Michaelis K; Vilcinskas A
    Arch Insect Biochem Physiol; 2020 Mar; 103(3):e21614. PubMed ID: 31498475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
    Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A
    Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraquat induces epigenetic changes by promoting histone acetylation in cell culture models of dopaminergic degeneration.
    Song C; Kanthasamy A; Jin H; Anantharam V; Kanthasamy AG
    Neurotoxicology; 2011 Oct; 32(5):586-95. PubMed ID: 21777615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acetylation of retinal histones in diabetes increases inflammatory proteins: effects of minocycline and manipulation of histone acetyltransferase (HAT) and histone deacetylase (HDAC).
    Kadiyala CS; Zheng L; Du Y; Yohannes E; Kao HY; Miyagi M; Kern TS
    J Biol Chem; 2012 Jul; 287(31):25869-80. PubMed ID: 22648458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LMK235, a small molecule inhibitor of HDAC4/5, protects dopaminergic neurons against neurotoxin- and α-synuclein-induced degeneration in cellular models of Parkinson's disease.
    Mazzocchi M; Goulding SR; Wyatt SL; Collins LM; Sullivan AM; O'Keeffe GW
    Mol Cell Neurosci; 2021 Sep; 115():103642. PubMed ID: 34119632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease.
    Pinho BR; Reis SD; Guedes-Dias P; Leitão-Rocha A; Quintas C; Valentão P; Andrade PB; Santos MM; Oliveira JM
    Pharmacol Res; 2016 Jan; 103():328-39. PubMed ID: 26657418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes.
    Wang Z; Zang C; Cui K; Schones DE; Barski A; Peng W; Zhao K
    Cell; 2009 Sep; 138(5):1019-31. PubMed ID: 19698979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A duplexed phenotypic screen for the simultaneous detection of inhibitors of the molecular chaperone heat shock protein 90 and modulators of cellular acetylation.
    Hardcastle A; Tomlin P; Norris C; Richards J; Cordwell M; Boxall K; Rowlands M; Jones K; Collins I; McDonald E; Workman P; Aherne W
    Mol Cancer Ther; 2007 Mar; 6(3):1112-22. PubMed ID: 17363504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA-dependent modulation of histone acetylation in Waldenstrom macroglobulinemia.
    Roccaro AM; Sacco A; Jia X; Azab AK; Maiso P; Ngo HT; Azab F; Runnels J; Quang P; Ghobrial IM
    Blood; 2010 Sep; 116(9):1506-14. PubMed ID: 20519629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crebinostat: a novel cognitive enhancer that inhibits histone deacetylase activity and modulates chromatin-mediated neuroplasticity.
    Fass DM; Reis SA; Ghosh B; Hennig KM; Joseph NF; Zhao WN; Nieland TJ; Guan JS; Kuhnle CE; Tang W; Barker DD; Mazitschek R; Schreiber SL; Tsai LH; Haggarty SJ
    Neuropharmacology; 2013 Jan; 64():81-96. PubMed ID: 22771460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyglutamine-expanded ataxin-3 impairs long-term depression in Purkinje neurons of SCA3 transgenic mouse by inhibiting HAT and impairing histone acetylation.
    Chou AH; Chen YL; Hu SH; Chang YM; Wang HL
    Brain Res; 2014 Oct; 1583():220-9. PubMed ID: 25139423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.